Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet effects on parathyroid gland volume in dialysis patients with secondary hyperplasia
2009-015723-90Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoints: Percent change in parathyroid gland volume and Serial parathyroid gland volume measurements. Started Feb 2010; status: active.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on 2009-015723-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015723-90.